883 related articles for article (PubMed ID: 31219699)
1. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
2. Acute
Schoch KM; Ezerskiy LA; Morhaus MM; Bannon RN; Sauerbeck AD; Shabsovich M; Jafar-Nejad P; Rigo F; Miller TM
Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34187891
[TBL] [Abstract][Full Text] [Related]
3. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice.
Zhang SS; Zhu L; Peng Y; Zhang L; Chao FL; Jiang L; Xiao Q; Liang X; Tang J; Yang H; He Q; Guo YJ; Zhou CN; Tang Y
J Neuroinflammation; 2022 Feb; 19(1):34. PubMed ID: 35123512
[TBL] [Abstract][Full Text] [Related]
4. Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer's disease.
Wang X; Xie Y; Fan X; Wu X; Wang D; Zhu L
Alzheimers Res Ther; 2024 Jun; 16(1):121. PubMed ID: 38831312
[TBL] [Abstract][Full Text] [Related]
5. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice.
Audrain M; Haure-Mirande JV; Mleczko J; Wang M; Griffin JK; St George-Hyslop PH; Fraser P; Zhang B; Gandy S; Ehrlich ME
Alzheimers Dement; 2021 Feb; 17(2):149-163. PubMed ID: 33314529
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of TREM2 accelerates the reduction of amyloid deposits and promotes neuronal regeneration in the hippocampus of amyloid beta1-42 injected mice.
Fan Y; Ma Y; Huang W; Cheng X; Gao N; Li G; Tian S
J Chem Neuroanat; 2019 Apr; 97():71-79. PubMed ID: 30790627
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
[TBL] [Abstract][Full Text] [Related]
9. TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice.
Jiang T; Wan Y; Zhang YD; Zhou JS; Gao Q; Zhu XC; Shi JQ; Lu H; Tan L; Yu JT
Mol Neurobiol; 2017 Mar; 54(2):855-865. PubMed ID: 26780455
[TBL] [Abstract][Full Text] [Related]
10. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
11. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
[TBL] [Abstract][Full Text] [Related]
12. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
[TBL] [Abstract][Full Text] [Related]
15. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
von Saucken VE; Jay TR; Landreth GE
Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
[TBL] [Abstract][Full Text] [Related]
16. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
Cui X; Qiao J; Liu S; Wu M; Gu W
Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
[TBL] [Abstract][Full Text] [Related]
18. Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice.
Lu J; Zhang J; Wang X; Yuan F; Xin B; Li J; Yang Q; Li X; Zhang J; Wang X; Fu J; Guo C
Brain Res Bull; 2024 Jun; 212():110969. PubMed ID: 38705540
[TBL] [Abstract][Full Text] [Related]
19. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.
Kajiwara Y; McKenzie A; Dorr N; Gama Sosa MA; Elder G; Schmeidler J; Dickstein DL; Bozdagi O; Zhang B; Buxbaum JD
Hum Mol Genet; 2016 Oct; 25(19):4315-4327. PubMed ID: 27516385
[TBL] [Abstract][Full Text] [Related]
20. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z
Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
